# Safety Study of the VEGA UV-A System to Treat Keratoconus

> **NCT01190306** · PHASE3 · TERMINATED · sponsor: **Topcon Medical Systems, Inc.** · enrollment: 127 (actual)

## Conditions studied

- Keratoconus

## Interventions

- **DEVICE:** The VEGA UV-A Illumination System
- **DRUG:** Riboflavin

## Key facts

- **NCT ID:** NCT01190306
- **Lead sponsor:** Topcon Medical Systems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-08
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 127 (ACTUAL)
- **Why stopped:** The sponsor terminated the study prior to data analysis for financial reasons.
- **Last updated:** 2022-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01190306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01190306, "Safety Study of the VEGA UV-A System to Treat Keratoconus". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01190306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*